Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Ending Cash Balance (2019 - 2026)

Updated

Aligos Therapeutics' Ending Cash Balance came in at $31.74 million for Q3 2026, down 24.5% from $42.06 million a year earlier but up 4.3% from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Ending Cash Balance (2019 - 2026) Analysis & Trends

For FY2025, Aligos Therapeutics' Ending Cash Balance was $18.41 million, down 50.4% from FY2024.

  • Ending Cash Balance carries a five-year compound annual growth rate of -39.2% (FY2020 to FY2025).
  • Going back by year, Ending Cash Balance was $37.11 million in FY2024 (-72.7%), $135.77 million in FY2023 (+66.7%), $81.46 million in FY2022 (-56.4%) and $186.98 million in FY2021 (-15.4%).
  • The five-year range for quarterly Ending Cash Balance is $18.41 million (Q4 2025) to $186.98 million (Q4 2021).
  • Year-over-year, Ending Cash Balance increased in three of the last eight quarters, with growth averaging 2.3%.
  • The fastest year-over-year change in Ending Cash Balance over five years came in Q1 2025 (growth of 203.2%), and the weakest in Q4 2024 (a decline of 72.7%).
  • Business Quant data shows ALGS's Ending Cash Balance at $30.42 million (Q2 2026), $30.15 million (Q1 2026) and $18.41 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 16.91 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 10.77 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 6.44 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 1.88 Bn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn - 31.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 31.74 Mn
Jun 30, 2026 30.42 Mn
Mar 31, 2026 30.15 Mn
Dec 31, 2025 18.41 Mn
Sep 30, 2025 42.06 Mn
Jun 30, 2025 18.77 Mn
Mar 31, 2025 73.87 Mn
Dec 31, 2024 37.11 Mn
Sep 30, 2024 35.44 Mn
Jun 30, 2024 45.15 Mn
Mar 31, 2024 24.37 Mn
Dec 31, 2023 135.77 Mn
Sep 30, 2023 70.50 Mn
Jun 30, 2023 90.87 Mn
Mar 31, 2023 79.07 Mn
Dec 31, 2022 81.46 Mn
Sep 30, 2022 86.52 Mn
Jun 30, 2022 71.19 Mn
Mar 31, 2022 106.12 Mn
Dec 31, 2021 186.98 Mn
API Access

Aligos Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ALGS&period=max&api_key=YOUR_API_KEY